I am currently pursuing postdoctoral research as part of a prosperity partnership collaboration between the Francis Crick Institute and GSK's Chemical Biology Department. My research is focused on expanding the the scope of ligandable targets across the human proteome by integrating covalent fragment-based discovery with chemical proteomics methods. I completed my PhD in the Department of Chemistry at the University of Cambridge in 2022, using fragment-based approaches to enable the discovery and elaboration of small molecules targeting mycobacterial CoA biosynthesis.